Evercore ISI Group Maintains Outperform on Boston Scientific, Raises Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an Outperform rating on Boston Scientific (NYSE:BSX) and raises the price target from $72 to $78.
April 25, 2024 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group has maintained an Outperform rating on Boston Scientific and increased the price target from $72 to $78.
The increase in the price target by a reputable analyst firm like Evercore ISI Group suggests a positive outlook on the stock's future performance. This endorsement is likely to instill confidence among investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100